Facebook  Twitter  Youtube  ISSUU  RSS  Email

Media Contacts

UK
Press Office
press@transparency.org.uk
+ 44 (0)20 3096 7695
Out of hours: Weekends; Weekdays (17.30-21.30): +44 (0)79 6456 0340


Twitter

TransparencyUK Our Anti-Bribery Guidance now includes summaries of anti #bribery legislation for… 🇧🇭 Bahrain 🇨🇱 Chile 🇨🇴 Colombia… https://t.co/tX0L6KtHiI
8hreplyretweetfavorite
TransparencyUK RT @anticorruption: 🔵COMING SOON: The Corruption Perceptions Index 2019 will be published on 23 January 2019. Stay tuned! #CPI2019 https://…
TransparencyUK Preventing @Khadija_Ismayil from leaving Azerbaijan is a clear attempt to silence and bully those who dare expose t… https://t.co/iFbIOX8bAs

Tag Cloud

Allegations anti-bribery anti-corruption summit AntiCorruption anti money laundering bribery BSkyB Cabinet Office companies conflict Corporate Cooperation corrupt capital Corruption corruption in the uk employment film financial secrecy Governance Government health Home Office journalists Letter Leveson Inquiry London Merkel metropolitan police moneylaundering money laundering offshore tax open governance pharmaceuticals PHP police ethics Prime Minister Register of Interests Research safe havens Social Accountability Trustees UK Unexplained Wealth Orders unmask the corrupt UWO vacancies

Stay Informed

Sign up for updates on Transparency International UK's work,corruption news from around the world and fundraising and events updates.

Clinical Trials: What are we not being told?

Written by James Sale on Tuesday, 5 May 2015

To ensure research and development of medical treatments becomes more transparent, Transparency International UK is pleased to support the AllTrials campaign calling for all past and present clinical trials to be registered and their results reported.


 

Clinical trials are a fundamental part of the Research & Development of medical treatments and the advancement of medical science. The World Medical Association’s statement of ethical research principles The Declaration of Helsinki, sets out that medical research should be registered that researchers have a duty to make publically available their results and that they are accountable for the completeness and accuracy of their reports, including negative and inconclusive results.

However this does not always happen. In fact it rarely happens within obligatory timeframes such as in US where most treatments approved by the US Food and Drug Administration (FDA) are required to register trial summary results with one year of completion; a New England Journal of Medicine (NEJM) study found that only 13.4% of trials complied with this legal requirement.

Research that is being conducted but is not reported can contribute to at best repetition of trials and medical science being held back and at worst the wrong medical decisions being made for a patient.

In 2013 The AllTrials campaign was launched and calls for all past and present clinical trials to be registered and their results reported. Transparency International UK is pleased to support the AllTrials Campaign. Transparency International UK believes that Research & Development should be undertaken in a manner that is transparent avoids conflicts of interest, and places the best corruption-resources-corruption-resources-healthcare outcomes at the heart of decision-making. This is one of the main objectives of Transparency International’s Pharmaceutical and Healthcare Programme.

Transparency International also believes that disclosure in Research & Development should go further than clinical trials.  That means more transparency in a number of areas by clinical research organisations private sector pharmaceutical companies and private investors, academic institutions, and national and regional corruption-resources-corruption-resources-health regulatory authorities.  This will help us ensure that ethical standards are raised, there is greater objectivity in research and more sunlight in the system, including disclosure of sources of funding.  Corruption thrives in dark corners.  Transparency is not the full remedy, but is a vital step.

{toggle | Information about the AllTrials campaign} The AllTrials campaign was launched in January 2013 and calls for all past and present clinical trials to be registered and their results reported. It is an initiative of Bad Science BMJ Centre for Evidence-based Medicine Cochrane Collaboration James Lind Initiative PLOS and Sense About Science and is being led in the US by Dartmouth’s Geisel School of Medicine and the Dartmouth Institute for Health Policy & Clinical Practice. Since then the AllTrials petition has been signed by 84143 people and 562 organisations.

 {/toggle}

Follow @TIUK_Health if you want the latest news from the TI-UK’s Pharmaceutical and Healthcare Programme.

2110

Read 2110 times Last modified on Tuesday, 24 November 2015 11:48
mm

James Sale

James is TI-UK's Project Officer heading the Pharmaceutical and Healthcare Programme. You can follow the programme on Twitter @TIUK_Health.

Leave a Reply

Contact Us | Sitemap | Privacy

UK Charity Number 1112842

Transparency International UK is a chapter of